Publications by authors named "Patricia A Macdonald"

23Publications

Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones.

Clin J Am Soc Nephrol 2013 Nov 8;8(11):1960-7. Epub 2013 Aug 8.

Nephrology Section, New York Harbor VA Medical Center, and Division of Nephrology, New York University Langone Medical Center, New York, New York;, †Global Medical Affairs, Takeda Pharmaceuticals International, Deerfield, Illinois;, ‡Clinical Science, and §Statistics, Takeda Global Research & Development Center, Inc., Deerfield, Illinois, ‖Experimental Medicine, Takeda California, San Diego, California.

View Article and Find Full Text PDF
November 2013

The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age.

BMC Geriatr 2012 Mar 21;12:11. Epub 2012 Mar 21.

Takeda Global Research & Development Centers, Inc, One Takeda Parkway, Deerfield, Illinois 60015, USA.

View Article and Find Full Text PDF
March 2012

African American patients with gout: efficacy and safety of febuxostat vs allopurinol.

BMC Musculoskelet Disord 2012 Feb 9;13:15. Epub 2012 Feb 9.

Rheumatology and Immunotherapy Center, 4225 W Oakwood Park Court, Franklin, WI 53132, USA.

View Article and Find Full Text PDF
February 2012

Treating hyperuricemia of gout: safety and efficacy of febuxostat and allopurinol in older versus younger subjects.

Nucleosides Nucleotides Nucleic Acids 2011 Dec;30(12):1011-7

University of Chicago, Pritzker School of Medicine, University of Chicago Medical Center, Chicago, Illinois 60637, USA.

View Article and Find Full Text PDF
December 2011

Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.

Arthritis Care Res (Hoboken) 2012 Feb;64(2):256-61

University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.

View Article and Find Full Text PDF
February 2012

Patient-reported outcomes in chronic gout: a report from OMERACT 10.

J Rheumatol 2011 Jul;38(7):1452-7

Medicine Service, Birmingham Veterans Affairs (VA) Medical Center and Division of Rheumatology, Department of Medicine, University of Alabama, Birmingham, AL 35294, USA.

View Article and Find Full Text PDF
July 2011

Febuxostat in gout: serum urate response in uric acid overproducers and underexcretors.

J Rheumatol 2011 Jul 15;38(7):1385-9. Epub 2011 May 15.

New York Veterans Affairs Medical Center, New York, NY, USA.

View Article and Find Full Text PDF
July 2011

Renal function in gout: long-term treatment effects of febuxostat.

J Clin Rheumatol 2011 Jan;17(1):7-13

Universal Clinical Research Center, Inc., 1737 Beaver Brook Lane, Hunt Valley, MD 21030-1603, USA.

View Article and Find Full Text PDF
January 2011

Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.

J Rheumatol 2009 Jun 13;36(6):1273-82. Epub 2009 Mar 13.

University of Chicago Medical Center, Pritzker School of Medicine, 5841 S. Maryland Ave., Chicago, IL 60637, USA.

View Article and Find Full Text PDF
June 2009

Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy.

Nucleosides Nucleotides Nucleic Acids 2008 Jun;27(6):585-91

Rheumatology Section, Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.

View Article and Find Full Text PDF
June 2008